Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parasitic Ulcer Treatment Trial Pilot
NCT03484507Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2018
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of povidone-iodine, prednisolone sodium phosphate in Acanthamoeba keratitis (AK), sponsored by University of California, San Francisco. Started Jan 2018; status: completed.
02
Drugs
povidone-iodineprednisolone sodium phosphate
03
Conditions
Acanthamoeba keratitis (AK)
Beyond the preview
Go deeper on NCT03484507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03484507.